Table 1.xls (5.5 kB)
ReIMAGINE risk study inclusion and exclusion criteria.
dataset
posted on 2022-02-24, 18:36 authored by Teresa Marsden, Neil McCartan, Louise Brown, Manuel Rodriguez-Justo, Tom Syer, Giorgio Brembilla, Mieke Van Hemelrijck, Ton Coolen, Gerhardt Attard, Shonit Punwani, Caroline M. Moore, Hashim U. Ahmed, Mark EmbertonReIMAGINE risk study inclusion and exclusion criteria.
History
Usage metrics
Keywords
sd +/- 10sd +/- 0recruit 1000 treatmentprimary outcomes includefirst site openedcurrently 4 academicstage 8804abnormal prostate examinationbased disease statusbased diagnostic pathway0 ), 12observational cohort studyscore 8805sd +/- 3naive men undergoingbased (~ 1novel prostate cancerprospective cohort studygleason 7 pcaprostate cancer 8805296 ),1 nonxlink ">t3bn0m0 ).stratification modelsslide imagingserum donatedseptember 2019risk modelsresolution scanningreferred ontopathology wholenovember 2019novel diagnosticsmight incorporategranted accessfuture analysisfull rangeethics approveddicom imagesdecember 2020clinical progressionartificial intelligence533 ).27 ).